Biotech - International Biopharmaceutical Industry

news

‘We have to make a stand’: Biotech leaders vow to break ties with Russia over Ukraine war

Hundreds of biotech leaders are pledging to stop working with Russian companies and to reject investment from Russian funds in response to the country's invasion of U...

4 March 2022 news Biotech | drugmaker

Continue Reading →

news

Amid biotech downturn, Atlas raises $450M to build new drug startups

Dive Brief: Atlas Venture, a prolific creator of biotech startups, has raised $450 million to form and invest in new drug companies, announcing Thursday the closin...

4 March 2022 news Atlas | Biotech

Continue Reading →

news

Third Harmonic, led by former Audentes CEO, launches with $155M in funding

Third Harmonic Bio, a biotech startup founded in 2019 by Atlas Venture, officially launched on Wednesday with $105 million in new funding to advance development of an...

18 February 2022 news Astellas | Audentes

Continue Reading →

news

A biotech wins the first FDA drug approval in a rare type of eye cancer

Dive Brief: The Food and Drug Administration on Tuesday granted approval to the first drug for a rare cancer of the eye that has spread elsewhere or grown too larg...

27 January 2022 news Biotech | cancer

Continue Reading →

news

Cortexyme to shift focus after FDA places hold on experimental Alzheimer’s drug

Dive Brief: The Food and Drug Administration has ordered California biotech Cortexyme to stop testing of an experimental Alzheimer's disease drug, notifying the dr...

27 January 2022 news Alzheimer | Biotech

Continue Reading →

news

Gene editing startup Metagenomi raises $175M to advance research pipeline

Metagenomi, a biotech startup that three months ago struck a research alliance with Moderna, has raised $175 million to expand and build on its early research explori...

27 January 2022 news Biotech | editing

Continue Reading →

news

GSK loses R&D chief Barron to high-powered startup amid investor pressure

Hal Barron, GlaxoSmithKline's top scientist and architect of the company's plans to revitalize its drug research, will step down from his role later this year to lead...

20 January 2022 news Barron | Biotech

Continue Reading →

news

M&A anxiety, Roche’s comeback plan and Vir’s omicron moment

The second day of the J.P. Morgan Healthcare Conference, much like the first, didn't include the type of market-moving acquisitions or announcements that might break ...

14 January 2022 news anxiety | biopharmaceutical

Continue Reading →

news

Arena, completing its turnaround, sells to Pfizer for nearly $7 billion

Pfizer has agreed to acquire Arena Pharmaceuticals for about $6.7 billion in a deal that validates the San Diego biotech’s plan to reshape itself around a portfolio o...

13 December 2021 news acquisition | Arena Pharmaceuticals

Continue Reading →

news

A high-profile gene therapy biotech takes aim at Huntington’s

Huntington’s was the first illness ever traced back to changes in a specific chromosome. And yet, almost 40 years since that discovery, no drug has been proven to alt...

10 December 2021 news Biotech | chromosome

Continue Reading →